99 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
trials of any of our product candidates fail to demonstrate safety and efficacy to the satisfaction of the Food and Drug Administration (“FDA … to the satisfaction of the FDA, the EMA and the European Commission or other comparable regulatory authorities, or do not otherwise produce favorable results
424B5
AUTL
Autolus Therapeutics plc
9 Feb 24
Prospectus supplement for primary offering
5:15pm
the required information and the shareholder proves to the satisfaction of the board of directors that no person in default as regards to supplying … ;
it is duly stamped or is duly certificated or otherwise shown to the satisfaction of the board of directors to be exempt from stamp duty; and
(vi
8-K
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
market risks and uncertainties and risks relating to the satisfaction of customary closing conditions for an offering of securities. Given
8-K
EX-1.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
for additional information on the part of the Commission shall have been complied with to your reasonable satisfaction;
(b) Goodwin Procter LLP, U.S. counsel
8-K
EX-10.1
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
(the “Initial ADSs”) to be purchased at the Initial Closing and, upon the satisfaction or waiver of the Subsequent Closing Trigger, ADSs with an aggregate … and (ii) the Qualified Financing Purchase Price. Upon the satisfaction or waiver of the Subsequent Closing Trigger, subject to the terms and conditions
S-3ASR
1ch4818wxj2rp80zjn
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.7
kl41lgsq7
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.9
yhrlb27u566bhzi
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.10
b39oppucgxxmpcu zrip
7 Feb 24
Automatic shelf registration
10:00pm
10-Q
EX-10.1
xk8bh 000569rzg
9 Nov 23
Quarterly report
4:18pm
10-Q
tzwsp085cje3brk31u
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.2
aylbms1 0xw9vrf
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.1
zn1x5j0gi
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.1
j2zkrq
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
obl94 1wm
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.1
wtr5lcqcl8xtat8ow
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
p35wy
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K
EX-1.1
qx92bn wjogbwi
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
424B5
pnpg 4qw4462quzxf409
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
ovijueuqzo u6tput2z4
8 Dec 22
Prospectus supplement for primary offering
4:10pm